Background: Decision-makers have begun to recognize Health-Related
Implications for policy makers • The Audit of Diabetes Dependent Quality of Life (ADDQoL) questionnaire is a tool that can be used in Argentina to measure the QoL of patients with diabetes when evaluating diabetes care programs.
•
The assessment of patient-reported outcomes could be easily incorporated into ambulatory practice and can provide valuable information when evaluating diabetes care programs. • While diabetes adversely affects QoL, patients treated with insulin in middle-income countries can maintain a high QoL similar to that observed in patients with diabetes in high-income countries.
• This can be a valuable argument to help overcome barriers that delay insulin treatment, like clinical inertia and patient resistance.
Background
Traditionally, the impact of a chronic disease has been measured in terms of either morbidity or mortality. However, researchers have begun to recognize Health-Related Quality of Life (HRQoL) as an important and measurable outcome of healthcare interventions. In patients with diabetes, it may predict an individual's capacity to manage this condition and to maintain long-term health and well-being (1) . Importantly, HRQoL data is also used by policy-makers to make decisions, particularly in regards to resource allocation for diabetes and other chronic diseases (2, 3 
Sample size
We estimated a sample size in order to obtain 95% Confidence Intervals (CI) of the QoL score with an error estimation of 0.30 points (semi-amplitude). Based on previous studies (16, 18, 19) , we anticipated a QoL mean score in T2DM patients of 1.20 ± 1.30 (mean ± SD). We included an additional 20% to the total sample to account for the possibility of loss of follow up or incomplete data based on experiences of previous field work conducted by our research group. The total sample size for our study based on these criteria required 90 T2DM patients treated with NPH insulin and 90 with IG.
Statistical analysis
Descriptive statistics were calculated for all variables measured. We used the Chi-Square test to explore the association between categorical variables. For continuous variables, we used the independent-sample T-Test or the Wilcoxon rank-sum test according to the distribution of the analysed variables. P-values of less than 0.05 (two-tailed) were considered to be statistically significant. We calculated the mean, standard deviation and median of the ADDQoL measures and performed subgroup analyses to examine the association of socio-demographic characteristics, level of glycemic control and diabetes complications with ADDQoL scores. Additionally, three robust regression models were built in order to adjust for potential confounders. Model selection was performed following a stepwise approach. Linearity was tested through augmented component-plusresidual plots. Outliers and potential influence were explored by calculating studentized residuals and Cook's distance for each observation. The reliability of the scale was determined by assessing the Cronbach alpha coefficient. Item missing rate was used to check feasibility. Data analyses were performed using Stata version 8.0 (Stata Corp, College Station, TX, USA).
Results

Patient characteristics
A total of 206 patients were invited to participate. Twentythree (11%) did not give their consent to participate or were excluded because of incomplete data. A total of 183 patients met the inclusion criteria and provided complete data for the analysis (93 receiving NPH and 90 receiving IG). Data on respondent characteristics are presented in Table 1 .
Quality of Life (QoL)
The scale showed a satisfactory feasibility since the item missing values were lower than 2%. Analyses of reliability showed a high internal consistency (Cronbach alpha: 0.89). The mean present QoL score was 0.98 (SD: 0.89), the diabetes specific QoL was -1.49 (SD: 0.90) and the mean AWI score on QoL -1.77 (SD: 1.58), indicating an overall negative impact of DM on QoL in T2DM patients treated with insulin. When we explored the association of socio-demographic characteristics, level of glycemic control and diabetes complications with ADDQoL scores ( 
Discussion
This is the first study describing HRQoL in T2DM patients treated with insulin using a diabetes specific instrument as ADDQoL in Argentina. Our results showed that T2DM has a negative impact on HRQoL in a group of Argentinean diabetes patients treated with insulin. However, mean AWI scored were not significantly different between patient treated with NPH or IG. As stated by Polonsky, the relationship between HRQoL and diabetes is bidirectional; aspects of diabetes may negatively impact on HRQoL, and impaired HRQoL may also negatively influence diabetes self-management and thus health outcomes (20) . Therefore, it is relevant to explore and understand those factors implicated in this relationship to Some studies found that better glycemic control was associated with better HRQoL and that complications were the most important disease-specific determinant of HRQoL (4, 21, 22) . However, other authors found no significant relationship between HRQoL and glycemic control (23) (24) (25) . In our study, glycemic control was not associated with HRQoL while patients with complications showed lower QoL scores than patients without complications, though this difference was not statistically significant. Additionally, men with T2DM reported higher scores in present QoL than women, a finding consistent with other studies in similar populations (9, 12, (26) (27) (28) (29) . Several studies showed that the most negatively impacted domains were those related to food, namely, 'freedom to eat', 'enjoyment of food' and 'freedom to drink'. Additionally, as found in our sample, 'worries about the future' is also one of the most affected domains (10, 16, (30) (31) (32) . As expected, the negative impact of diabetes varies depending on the characteristics of the patients. For example, the domain 'worries about the future' had particularly large negative impact on HRQoL, in the subgroup of subjects younger than 65 years old. Collins et al. (30) showed that older age (60 years of age) might be associated with higher diabetes-related QoL scores, although this statistically significant association was diminished after adjusting for relevant factors. Sundaram et al. (33) also reported that older age (60 years of age) was independently associated with higher ADDQoL scores in a multivariate analysis. Differences between genders were also seen in domains such as sex life, friendship and social life and enjoyment of food, which is consistent with findings in other studies (9, 26) . Our main limitation is that the study sample was drawn from specialized diabetes clinics rather than randomly selected centers, affecting the generalizability of our findings. Patients treated in specialist clinics usually have high health coverage and higher levels of diabetes education than those T2DM patients treated in public hospitals with no health coverage. On the other hand, the relatively small sample size did not allow us to further explore the potential association of QoL with socio-demographic characteristics and different aspects of the disease.
Conclusion
The ADDQoL questionnaire is a tool that can be used in Argentina to measure the QoL of patients with diabetes when evaluating diabetes care programs. The scores of QoL in our selected T2DM patient population did not differ from those reported in studies that included patients from high-income countries where there is access to a high level of diabetes care. While diabetes adversely affects QoL, patients treated with insulin in middle-income countries can maintain a high QoL similar to that observed in patients with diabetes in highincome countries. In future studies, it would be advisable to implement this questionnaire in a different patient population, including lower educated patients with no health coverage treated in public health centers and T2DM patients exclusively on oral antidiabetic drugs. We strongly feel that the assessment of patient-reported outcomes should be extended and incorporated into ambulatory practice and taken into account in the evaluation of diabetes care programs. Even though Argentina has a National Diabetes Program (34) which supplies free insulin for all diabetes patients, clinical inertia and patient resistance are still barriers that delay insulin treatment. We expect that the results of this study will increase healthcare providers' awareness of patients' perceived QoL and help to overcome these barriers.
